M. Slaoui Moncef's most recent trade in Vaxcyte Inc was a trade of 26,061 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 22, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vaxcyte Inc | Moncef M. Slaoui | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2026 | 26,061 | 26,061 | - | - | Stock Option (right to buy) | |
| Arcturus Therapeutics Holdings Inc | Moncef M. Slaoui | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 15,000 | 15,000 | - | - | Stock option (right to buy) | |
| Arcturus Therapeutics Holdings Inc | Moncef M. Slaoui | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2025 | 15,000 | 15,000 | - | - | Stock option (right to buy) | |
| Arcturus Therapeutics Holdings Inc | Slaoui M. Moncef | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2024 | 15,000 | 15,000 | - | - | Stock option (right to buy) | |
| Arcturus Therapeutics Holdings Inc | M. Slaoui Moncef | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2024 | 14,794 | 14,794 | - | - | Stock option (right to buy) |